Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)

NCT05597761 is registered in ClinicalTrials.gov with Oliver Cornely, MD as lead sponsor.

NCT NCT05597761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05597761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)
Lead sponsor
Oliver Cornely, MD
Phase
Observational
Overall status
Active, not recruiting
Start date
May 15, 2023
Completion date
December 31, 2025
Enrollment
49 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult, covid-19, immunocompromised patients